Abstract and Introduction Self-Assessment Pain Scales: Are They Reliable in Older Individuals? Patients With Cognitive Impairment: Should One Routinely Use Observational Scales? Conclusion ...
The possibility to increase the number of verbal descriptors in VRS scales has also limitations. A study by Rosier et al. [30] showed that among 15 adjectives offered to describe their pain ...
The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback